OPDYTA 40/100 mg (Nivolumab)
Category:
Manufacturer : Bristol-Myers Squibb
Composition : Nivolumab 40/100 mg
Opdyta 100 mg Injection is used in the treatment of melanoma, non-small cell lung cancer, head and neck cancer, kidney cancer and non-Hodgkin lymphoma (NHL).
Ask for Quote : [email protected]
Specialty:
View this product at mbapharmaceuticals.com